1[1]Grines CL,CoxDA,Stone GW,et al.Coronary angiopalsty with or without stent implantation for acute myocardial infarction.N Engl J Med,1999,341:1949～1956
2[2]Neumarm FJ,Kosa I,Dickfield T,et al.Recovery of myocardial peffusion in acute myocardial infarction after successful balloon angioplasty and stent placement in the infarctrelated coronary artery.JACC,1997,30:1270～1276
3[3]Herrmann HC,Moliitemo DJ,Ohman EM,et al.Facilitation of early percutaneous coronary intervention after reteplase with or without abciximb in acute myocardial infarction:results from the SPEED(GUSTO04 pilot) Trial.JACC,2000,36:1489～1496
4[4]Antman EM,Giugiiano RP,Gibson CM,et al.Abciximab facilitates the rate and extent of thrombolysis:results of the Thrombolysis In Myocardial Infacfion(TIMI)14 trial.Circulation,1996,99:2720～2732
5[5]Warkentin TE,Levine MN,Hirsh J,et al.Randomlsed placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina:the CAPTFURE Study.Lancet,1997,349:1429～1435
6[6]Aaron Kugelmass.Platelet Recetor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS)Study Investigators.Inhibition of the platelet gtyceprotein Ⅱb/Ⅲa recepter with tirofiban in unstable angina and nan-Qwave myocardial infarction.N Engl J Med,1998,338:1488～1497
7[7]PARAGONB(platelet Ⅱb/Ⅲa Antagonism for the Reduction of Acute coronary syndrome events in Global Orgallixation Network B).Source from Rothe Internet news,2001
8[8]Aaron Kugelmass.The PURSIT Trial Investigators.Inhibition of platdet glycoprotein Ⅱb/Ⅲawith eptifibatide in patients with acute coronary syndromes.The PURSUIT Trial Investigators:platelet Glyeoprotein Ⅱb/Ⅲa in Unstasle Angina:Receptor Suppression Using Integrilin Therapy.N Engl J Med,1998,339:436～443
9[9]Cannon C.TACTICS(Treat angina with Aggrastat I Determine Cost of Therapy with an Invasive or Conservative Strategy)-TIMI 18(abstr).Clin Cardiol,2001,24(suppl):86
